Tg(Vav1-NUP98/HOXD13)G2Apla
Transgene Detail
|
Symbol: |
Tg(Vav1-NUP98/HOXD13)G2Apla |
Name: |
transgene insertion G2, Peter Aplan |
MGI ID: |
MGI:4357686 |
Synonyms: |
NHD13 tg |
Transgene: |
Tg(Vav1-NUP98/HOXD13)G2Apla Location: unknown
|
Alliance: |
Tg(Vav1-NUP98/HOXD13)G2Apla page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Vav1-NUP98/HOXD13)G2Apla expresses
2 genes
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
HOXD13 (3239) |
|
|
human |
NUP98 (4928) |
|
|
|
|
|
Mutation details: A transgenic construct containing cDNA of the amino-terminal region of the human nucleoporin 98kDa (NUP98) fused to the homeodomain of the human homeobox D13 (HOXD13) under the control of the 3' and 5' mouse vav 1 oncogene (Vav1) regulatory elements and SV40 polyadenylation site sequence was injected into fertilized C57BL/6 mouse eggs. Founder line G2 was subsequently established. The transgene is expressed specifically in hematopoietic tissues and is detected in thymus, spleen, and bone marrow and not in brain, liver, and kidney (by Northern blot analysis of total RNA).
(J:107446)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:107446 Lin YW, et al., NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood. 2005 Jul 1;106(1):287-95 |
All: |
28 reference(s) |
|